The Research and Development team at Navitor Pharmaceuticals focuses on the discovery and development of innovative therapies that target cellular nutrient signaling pathways, particularly through the mTORC1 pathway. Comprising experts in pharmacology, process chemistry, and scientific leadership, the team collaboratively designs, processes, and evaluates new drug candidates, ensuring they align with the company's strategic goals in advancing biopharmaceuticals.